Dr. Sten Vermund, Dean, Yale School of Public Health Congratulates Aquavit PharmaceuticalsAbout Dr. Sten Vermund: Dr. Sten Vermund is a pediatrician and infectious disease epidemiologist focused on diseases of low and middle in...
EU Intellectual Property Office Revokes Counterfeiter's Fake AQUAGOLD® Design RegistrationDecember 10, 2020: New York, NY Aquavit Pharmaceuticals, Inc. ("Aquavit") received a decision from the European Union Intellectual Proper...
Aquavit Pharmaceuticals, Inc. Wins Default Judgement Against CounterfeiterSeptember 08, 2020: New York, NY Aquavit Pharmaceuticals, Inc. ("Aquavit") won a default judgement against counterfeiter in the United St...
Aquavit Files For New COVID-19 Self-Administrable Vaccine Delivery Method and Technology PatentAugust 18, 2020: New York, NY Aquavit Files For New COVID-19 Self-Administrable Vaccine Delivery Method and Technology Patent Through Fas...
Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against CounterfeitersAugust 13, 2020: New York, NY Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters for Cont...
Aquavit Unveils Its Platform Technology Addressing COVID-19 at 2020 BIO International ConferenceJune 08, 2020: New York, NY Aquavit Pharmaceuticals Unveils Its Platform Technology Addressing COVID-19 at 2020 BIO International Confere...
New Drug Delivery Platform and Immunotherapeutic Compositions Against CancerApril 15, 2020: New York, NY New Drug Delivery Platform and Immunotherapeutic Compositions Against Cancer Using Proprietary Microchannel ...
New Drug Delivery Platform and Vaccine Compositions for Immunizing Patients Against COVID-19 March 27, 2020: Aquavit Pharmaceuticals, Inc. Announces Filing of New Patent Applications for a New Drug Delivery Platform and Vaccine Co...
Aquavit Pharmaceuticals, Inc. Introduces Jill Waibel, MD., New Chief Medical Officer (CMO) June 3, 2019: New York, NY New York-based Aquavit Pharmaceuticals, Inc. is delighted to introduce Dr. Jill Waibel as its new Chief Medica...
Chief Executive Officer Sobin Chang Presenting at World-Renowned BIO International Convention June 3, 2019: New York, NY Aquavit Pharmaceuticals, Inc. announced today that Chief Executive Officer Sobin Chang will be presenting at t...
Police Requests Indictment of U-BioMed and CEO Nyunshik Eum for Trademark Infringement & CounterfeitSeoul, South Korea May 28, 2019 – Aquavit Life Sciences, Inc. today received an official notice from the police that they have requested ...
Preliminary Injunction Order Against Counterfeiters on Patent and Trademark Infringement CaseNEW YORK, April 29, 2019 – Aquavit Pharmaceuticals, Inc. secured a Preliminary Injunction Order in the United States District Court for t...
ALERT AQUAGOLD® fine touch™ COUNTERFEIT March 4, 2019 Dear Valued Customers: It has come to our attention that an illegal Korean operator has been falsely advertising as if they...
Aquavit Life Sciences, Inc. Announces Acquisition Of Manufacturer Hail Co. Ltd. SEOUL, Nov.13, 2017 / South Korea/ — Aquavit Life Sciences, Inc. (Aquavit) is pleased to announce the acquisition of Korean manufacturing...
Aquavit Pharmaceuticals Adds New Patent To Its High-Tech Medical PortfolioNew York, NEW YORK, September 1, 2017 Aquavit Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office (USPTO) ...
Aquavit’s iMicrotox™ (IMX-001) Study Receives IRB Approval Las Vegas, NEVADA, August 31, 2017 Aquavit pharmaceuticals announced today that it has received a green light from the IRB, to conduct in...
PIRACY ALERTPIRACY ALERT October 21, 2016 Dear Valued Customers and Partners of Aquavit: RE: Illegal Piracy Activities in Korea and China It has come...
Aquavit Pharmaceuticals Registers AQUAGOLD® Device in Korea NEW YORK, May 30, 2015 /USA/ — Aquavit Pharmaceuticals Inc. (Aquavit) is pleased to announce that it has officially registered its fluid ...
Dr. Mary Lupo Joins Aquavit Pharmaceuticals’ Scientific Advisory Board New York, NEW YORK, November 4, 2014 Aquavit Pharmaceuticals welcomes Mary Lupo, MD, FAAD as its newest Scientific Advisory Board member....
Aquavit Pharmaceuticals Announces Official Launch of AQUAGOLD® fine touch™ at the 72nd AAD MeetingDenver, COLORADO, March 23, 2014 Aquavit Pharmaceuticals, Inc., a New York-based technology-driven life science company, officially launc...
